227 related articles for article (PubMed ID: 26786396)
1. Assessing the utility of Xpert(®) MTB/RIF as a screening tool for patients admitted to medical wards in South Africa.
Heidebrecht CL; Podewils LJ; Pym AS; Cohen T; Mthiyane T; Wilson D
Sci Rep; 2016 Jan; 6():19391. PubMed ID: 26786396
[TBL] [Abstract][Full Text] [Related]
2. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.
Lawn SD; Brooks SV; Kranzer K; Nicol MP; Whitelaw A; Vogt M; Bekker LG; Wood R
PLoS Med; 2011 Jul; 8(7):e1001067. PubMed ID: 21818180
[TBL] [Abstract][Full Text] [Related]
3. Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
Ershova JV; Volchenkov GV; Somova TR; Kuznetsova TA; Kaunetis NV; Kaminski D; Demikhova OV; Chernousova LN; Vasilyeva IA; Kerr EM; Cegielski JP; Kurbatova EV
BMC Infect Dis; 2020 Jul; 20(1):543. PubMed ID: 32711457
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
5. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
[TBL] [Abstract][Full Text] [Related]
6. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
[TBL] [Abstract][Full Text] [Related]
7. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
[TBL] [Abstract][Full Text] [Related]
8. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa.
Evans D; Sineke T; Schnippel K; Berhanu R; Govathson C; Black A; Long L; Rosen S
BMC Health Serv Res; 2018 Dec; 18(1):973. PubMed ID: 30558670
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the use of GeneXpert MTB/RIF in a zone with high burden of tuberculosis in Thailand.
Pongpeeradech N; Kasetchareo Y; Chuchottaworn C; Lawpoolsri S; Silachamroon U; Kaewkungwal J
PLoS One; 2022; 17(7):e0271130. PubMed ID: 35895742
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from Ethiopia.
Biadglegne F; Mulu A; Rodloff AC; Sack U
Tuberculosis (Edinb); 2014 Sep; 94(5):502-5. PubMed ID: 24931451
[TBL] [Abstract][Full Text] [Related]
11. GeneXpert
Christopher PM; ; Widysanto A
Int J Mycobacteriol; 2019; 8(4):351-358. PubMed ID: 31793505
[TBL] [Abstract][Full Text] [Related]
12. The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China.
Lu J; Li H; Dong F; Shi J; Yang H; Han S; Chu P; Zhao Y; Song W; Guo Y; Zhao S
Biomed Res Int; 2017; 2017():5857369. PubMed ID: 29359155
[TBL] [Abstract][Full Text] [Related]
13. Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study.
van Kampen SC; Susanto NH; Simon S; Astiti SD; Chandra R; Burhan E; Farid MN; Chittenden K; Mustikawati DE; Alisjahbana B
PLoS One; 2015; 10(6):e0123536. PubMed ID: 26075722
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana.
Boakye-Appiah JK; Steinmetz AR; Pupulampu P; Ofori-Yirenkyi S; Tetteh I; Frimpong M; Oppong P; Opare-Sem O; Norman BR; Stienstra Y; van der Werf TS; Wansbrough-Jones M; Bonsu F; Obeng-Baah J; Phillips RO
Int J Mycobacteriol; 2016 Jun; 5(2):226-30. PubMed ID: 27242237
[TBL] [Abstract][Full Text] [Related]
15. Chest X-ray vs. Xpert® MTB/RIF assay for the diagnosis of sputum smear-negative tuberculosis in Uganda.
Wekesa C; Kirenga BJ; Joloba ML; Bwanga F; Katamba A; Kamya MR
Int J Tuberc Lung Dis; 2014 Feb; 18(2):216-9. PubMed ID: 24429316
[TBL] [Abstract][Full Text] [Related]
16. Xpert® MTB/RIF: Usefulness for the diagnosis of tuberculosis and resistance to rifampicin.
Vergara Gómez A; González-Martín J; García-Basteiro AL
Med Clin (Barc); 2017 Nov; 149(9):399-405. PubMed ID: 28739268
[TBL] [Abstract][Full Text] [Related]
17. Test and Treat TB: a pilot trial of GeneXpert MTB/RIF screening on a mobile HIV testing unit in South Africa.
Bassett IV; Forman LS; Govere S; Thulare H; Frank SC; Mhlongo B; Losina E
BMC Infect Dis; 2019 Feb; 19(1):110. PubMed ID: 30717693
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the Diagnostic Accuracy of Xpert MTB/RIF Assay in Pulmonary Tuberculosis.
Sharma SK; Kohli M; Yadav RN; Chaubey J; Bhasin D; Sreenivas V; Sharma R; Singh BK
PLoS One; 2015; 10(10):e0141011. PubMed ID: 26496123
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the GeneXpert MTB/RIF assay on extrapulmonary and respiratory samples other than sputum: a low burden country experience.
Pandey S; Congdon J; McInnes B; Pop A; Coulter C
Pathology; 2017 Jan; 49(1):70-74. PubMed ID: 27913043
[TBL] [Abstract][Full Text] [Related]
20. GeneXpert MTB/RIF Is Superior to BBD Max MDR-TB for Diagnosis of Tuberculosis (TB) in a Country with Low Incidence of Multidrug-Resistant TB (MDR-TB).
Mokaddas EM; Ahmad S; Eldeen HS
J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30971464
[No Abstract] [Full Text] [Related]
[Next] [New Search]
